Evidence map›Paper›PMID 41371441›Full record

ArticleMolecular metabolism2026

Sustained diabetes remission induced by FGF1 involves a shift in transcriptionally distinct AgRP neuron subpopulations.

Nadia N Aalling, Petar V Todorov, Shad Hassan, Dylan M Belmont-Rausch, Oliver Pugerup Christensen, Claes Ottzen Laurentiussen, Anja M Jørgensen, Kimberly M Alonge, Jarrad M Scarlett, Zaman Mirzadeh and 3 more

Abstract read
In one paragraph

Article in Molecular metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nadia N AallingNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Petar V TodorovNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Shad HassanNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Dylan M Belmont-RauschNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Oliver Pugerup ChristensenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Claes Ottzen LaurentiussenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Anja M JørgensenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Kimberly M AlongeUW Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA, USA; McKnight Brain Institute, Department of Neuroscience, University of Florida, Gainesville, FL, USA.
Jarrad M ScarlettUW Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA, USA.
Zaman MirzadehDepartment of Neurosurgery, Barrow Neurological Institute, Phoenix, AZ, USA.
Jenny M BrownNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Michael W SchwartzUW Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA, USA.
Tune H PersNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark. Electronic address: tune.pers@sund.ku.dk.

Funding

PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON · 1986 to 2026
$30.4M
Thermoregulatory circuits that regulate feedingR01DK124238 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, Tune Hannes Pers · 2020 to 2026
$3.9M
Maternal immune activation remodeling of offspring glycosaminoglycan sulfation patterns during neurodevelopmentDP2AI171150 · NIAID · UNIVERSITY OF WASHINGTON · PI Kimberly Michele Alonge · 2023 to 2026
$2.0M
NIAID NIH HHS DP2 AI171150NIDDK NIH HHS P30 DK035816NIDDK NIH HHS R01 DK124238
6 · The paper itself

Abstract

In rodent models of type 2 diabetes, a single intracerebroventricular (icv) injection of fibroblast growth factor 1 (FGF1) induces sustained remission of hyperglycemia. Overactive agouti-related peptide (AgRP) neurons, located in the hypothalamic arcuate nucleus, are a hallmark of diabetic states, and their long-term inhibition has been linked to FGF1's antidiabetic effects. To investigate the underlying mechanism(s), we performed single-nucleus RNA sequencing of the mediobasal hypothalamus at Days 5 and 14 post-injection in wild-type and diabetic (Lep

Indexed as

Agouti-Related ProteinDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Fibroblast Growth Factor 1NeuronsAnimalsArcuate Nucleus of HypothalamusHypothalamusMaleMiceMice, Inbred C57BLMice, ObeseAgouti-Related ProteinAgrp protein, mouseFibroblast Growth Factor 1AgRP neuron heterogeneityDiabetesFibroblast growth factor 1 (FGF1)Perineuronal netsSingle nucleus RNA-seqSpatial transcriptomics

Identifiers

PMID41371441
PMCPMC12808567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.